Finerenone in heart failure: walking a fine line.
Publication
, Journal Article
Naegele, M; Hernandez, AF; Ruschitzka, F
Published in: Eur Heart J
July 14, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
July 14, 2016
Volume
37
Issue
27
Start / End Page
2115 / 2117
Location
England
Related Subject Headings
- Naphthyridines
- Humans
- Heart Failure
- Exercise Test
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Naegele, M., Hernandez, A. F., & Ruschitzka, F. (2016). Finerenone in heart failure: walking a fine line. Eur Heart J, 37(27), 2115–2117. https://doi.org/10.1093/eurheartj/ehw155
Naegele, Matthias, Adrian F. Hernandez, and Frank Ruschitzka. “Finerenone in heart failure: walking a fine line.” Eur Heart J 37, no. 27 (July 14, 2016): 2115–17. https://doi.org/10.1093/eurheartj/ehw155.
Naegele M, Hernandez AF, Ruschitzka F. Finerenone in heart failure: walking a fine line. Eur Heart J. 2016 Jul 14;37(27):2115–7.
Naegele, Matthias, et al. “Finerenone in heart failure: walking a fine line.” Eur Heart J, vol. 37, no. 27, July 2016, pp. 2115–17. Pubmed, doi:10.1093/eurheartj/ehw155.
Naegele M, Hernandez AF, Ruschitzka F. Finerenone in heart failure: walking a fine line. Eur Heart J. 2016 Jul 14;37(27):2115–2117.
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
July 14, 2016
Volume
37
Issue
27
Start / End Page
2115 / 2117
Location
England
Related Subject Headings
- Naphthyridines
- Humans
- Heart Failure
- Exercise Test
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology